Groundbreaking neurostimulation technology offers hope and healing for difficult-to-manage pain. Chronic low back pain, a formidable foe causing disability and soaring healthcare costs, now faces a ...

Physicians at the UAB Pain Treatment Clinic are offering a new treatment for chronic low back pain. The treatment focuses on stimulating one of the key stabilizing muscles of the lumbar spine, the ...

DUBLIN--(BUSINESS WIRE)--Mainstay Medical today announced that the United States Centers for Disease Control and Prevention (CDC) has designated an International Classification of Diseases, Tenth ...

Axial myopathy is a general term for a group of myopathies affecting the axial muscles. Axial myopathy appears to be a grossly underestimated feature of many muscle diseases and often overlooked ...

Low back pain is the biggest musculoskeletal issue affecting the world today. At any given moment, up to 33 percent of the population is dealing with low back pain. It is one of the most common ...

“This is a totally new way of treating back pain,” said Prentiss Lawson Jr., M.D., an associate professor in the UAB Department of Anesthesiology and Perioperative Medicine and program director of the ...

Mainstay Medical Holdings plc has won U.S. FDA approval for its Reactiv8 implantable neurostimulation device. The company is eyeing a commercial launch of the system in early 2021. The FDA approved ...